MSF frequently publishes updates, press releases, and other forms of communication about its work in roughly 70 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

January 28, 2015

NEW YORK—As negotiators hold closed-door meetings in Manhattan this week over a secretive trade deal that could affect the health of half a billion people, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) took its protest against the Trans-Pacific Partnership (TPP) to the skies Wednesday, flying an aerial banner that read “Doctors to Obama: Keep #TPP Away From Our Medicines” along the Hudson River.

January 26, 2015

Secret meeting this week in New York a chance to remove provisions that threaten access to lifesaving medicines.

January 23, 2015

New intellectual property "think tank" draft policy already showing alarming trend.

January 20, 2015

Doctors Without Borders/Médecins Sans Frontières (MSF) today called on pharmaceutical companies GlaxoSmithKline (GSK) and Pfizer to slash the price of the pneumococcal vaccine to US$5 per child in developing countries, ahead of a major vaccination donor conference in Berlin.

January 16, 2015

Vaccination is a cornerstone of Doctors Without Borders/Médecins Sans Frontières’ (MSF) work to reduce illness and death caused by preventable diseases. While global immunization coverage reached 84 percent in 2013, in some places vaccination rates have stagnated, leaving behind children chronically unimmunized and unprotected. For more than 40 years, MSF has been at the forefront of vaccine delivery in crisis contexts, and in response to outbreaks of vaccine-preventable diseases. We also conduct routine immunization in areas where health systems have failed.

December 08, 2014

This article was originally published in The Wall Street Journal.

December 03, 2014

NEW YORK—A United States government program meant to reward pharmaceutical companies for investing in research and development (R&D) for neglected diseases, and which will soon include Ebola on its list of eligible diseases, is enriching drug companies without ensuring that patients, treatment providers, or governments have access to these lifesaving drugs at an affordable price, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) Monday.

November 18, 2014

“The pharmaceutical industry-supported Tufts Center for the Study of Drug Development claims it costs US$2.56 billion to develop a new drug today; but if you believe that, you probably also believe the earth is flat.

“GlaxoSmithKline’s CEO Andrew Witty himself says the figure of a billion dollars to develop a drug is a myth; this is used by the industry to justify exorbitant prices. We need to ask ourselves, if the CEO of a top pharmaceutical company says it’s a myth that it costs a billion dollars to develop a drug, can we really take this new figure 2.56 billion seriously?

October 31, 2014

Doctors Without Borders/Médecins Sans Frontières (MSF) would like to submit the following written comments to the 2014 United States Trade Representative (USTR) Special 301 Out-of-Cycle Review of India’s intellectual property legal regime and policies.

September 26, 2014

As Indian prime minister Narendra Modi makes his first official visit to the US, MSF is urging the Indian government to resist US pressure to drop the use of public health safeguards in its intellectual property laws.

Pages